GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Otsuka Holdings Co Ltd (OTCPK:OTSKY) » Definitions » EV-to-EBIT

Otsuka Holdings Co (Otsuka Holdings Co) EV-to-EBIT : 18.09 (As of May. 05, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Otsuka Holdings Co EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Otsuka Holdings Co's Enterprise Value is $20,862 Mil. Otsuka Holdings Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was $1,153 Mil. Therefore, Otsuka Holdings Co's EV-to-EBIT for today is 18.09.

The historical rank and industry rank for Otsuka Holdings Co's EV-to-EBIT or its related term are showing as below:

OTSKY' s EV-to-EBIT Range Over the Past 10 Years
Min: 4.42   Med: 12.13   Max: 34.14
Current: 18.65

During the past 13 years, the highest EV-to-EBIT of Otsuka Holdings Co was 34.14. The lowest was 4.42. And the median was 12.13.

OTSKY's EV-to-EBIT is ranked worse than
52.77% of 667 companies
in the Drug Manufacturers industry
Industry Median: 17.86 vs OTSKY: 18.65

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Otsuka Holdings Co's Enterprise Value for the quarter that ended in Mar. 2024 was $20,937 Mil. Otsuka Holdings Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was $1,153 Mil. Otsuka Holdings Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 5.51%.


Otsuka Holdings Co EV-to-EBIT Historical Data

The historical data trend for Otsuka Holdings Co's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Otsuka Holdings Co EV-to-EBIT Chart

Otsuka Holdings Co Annual Data
Trend Mar14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.08 11.13 12.33 11.61 17.41

Otsuka Holdings Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.80 11.41 10.45 17.41 18.54

Competitive Comparison of Otsuka Holdings Co's EV-to-EBIT

For the Drug Manufacturers - General subindustry, Otsuka Holdings Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Otsuka Holdings Co's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Otsuka Holdings Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Otsuka Holdings Co's EV-to-EBIT falls into.



Otsuka Holdings Co EV-to-EBIT Calculation

Otsuka Holdings Co's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=20861.750/1152.962
=18.09

Otsuka Holdings Co's current Enterprise Value is $20,862 Mil.
Otsuka Holdings Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,153 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Otsuka Holdings Co  (OTCPK:OTSKY) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Otsuka Holdings Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 ) =EBIT / Enterprise Value (Q: Mar. 2024 )
=1152.962/20937.3464
=5.51 %

Otsuka Holdings Co's Enterprise Value for the quarter that ended in Mar. 2024 was $20,937 Mil.
Otsuka Holdings Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,153 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Otsuka Holdings Co EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Otsuka Holdings Co's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Otsuka Holdings Co (Otsuka Holdings Co) Business Description

Traded in Other Exchanges
Address
2-9 Kanda-Tsukasamachi, Chiyoda-ku, Tokyo, JPN, 101-0048
Otsuka Holdings Co Ltd is a Japan-based company operates in pharmaceuticals, nutraceuticals and consumer products. Business activity of the company includes providing healthcare solutions in the areas of nervous system, oncology, cardiovascular system, respiratory system, infectious disease and others. It is also engaged in the research and development of functional foods and beverages, such as electrolyte drinks, nutritional foods, soy snacks and dietary food. In addition it also operates multiple businesses related to chemicals, transportation, warehousing, and electronic equipment. Geographically, it operates in Japan, North America and in other regions of which Japan accounts for larger share of revenue.